Correlation Between Hepion Pharmaceuticals and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and X4 Pharmaceuticals, you can compare the effects of market volatilities on Hepion Pharmaceuticals and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and X4 Pharmaceuticals.
Diversification Opportunities for Hepion Pharmaceuticals and X4 Pharmaceuticals
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Hepion and XFOR is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and X4 Pharmaceuticals
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to generate 0.26 times more return on investment than X4 Pharmaceuticals. However, Hepion Pharmaceuticals is 3.82 times less risky than X4 Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 65.00 in Hepion Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 1.45 from holding Hepion Pharmaceuticals or generate 2.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hepion Pharmaceuticals vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Hepion Pharmaceuticals |
| X4 Pharmaceuticals |
Hepion Pharmaceuticals and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hepion Pharmaceuticals and X4 Pharmaceuticals
The main advantage of trading using opposite Hepion Pharmaceuticals and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |